FreeIn Brief ACS CAN: Executive order on pre-existing condition protections unlikely to help cancer patients and survivors October 02, 2020Vol.46 No.37
Conversation with The Cancer LetterFree Leonidas Platanias: These incidents are “really shocking and disturbing” October 02, 2020Vol.46 No.37By Alexandria Carolan
Conversation with The Cancer LetterFree Pamela Kunz: “In any other industry, if someone had behavior like that, they would be fired.” October 02, 2020Vol.46 No.37By Alexandria Carolan
Free In their own words: Responses to The Cancer Letter survey on gender bias October 02, 2020Vol.46 No.37
Free AACR report: COVID struck as science was making unprecedented impact on cancer September 25, 2020Vol.46 No.36By Alexandria Carolan
COVID-19 & CancerFree IL-6 antagonists may have a role in fighting COVID-19 after all September 25, 2020Vol.46 No.36By Paul Goldberg
Drugs & TargetsFree Rhenium NanoLiposomes receives Fast Track Designation from FDA for glioblastoma treatment September 18, 2020Vol.46 No.35
Drugs & TargetsFree Elicio Therapeutics and Moffitt collaborate to study AMP-CD19 + CD19 CAR T cells September 18, 2020Vol.46 No.35
Drugs & TargetsFree UCSD, Cofactor Genomics collaborate to improve patient outcomes in metastatic head and neck cancer September 18, 2020Vol.46 No.35
Clinical RoundupFree Korean study examines the combined impact of aspirin, metformin, and statin’s impact on lung cancer risk September 18, 2020Vol.46 No.35
